Scientists are uncovering how the placenta, long viewed as a temporary pregnancy organ, acts as a powerful biological predictor of lifelong health, linking prenatal environments to future risks of ...

"Awesome game. Awesome game of resiliency, the group kind of sticking together. I think it's a good example of not every game is going to be perfect. There's going to be highs and lows. For our guys ...

A chronological map of the fetal brain reveals when key cells emerge and provides clues about autism and cancer.

KOMZIFTI™ (ziftomenib) launch generating early revenue momentum and rapid payer coverage decisions – – Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, su ...

Scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have developed a new way to determine atomic structures from nanocrystals previously considered unusable, ...

6 core challenges that researchers must consider as the race to create models that are ever closer to real human embryos heats up.

Blueprint Medicines, a Sanofi company, today announced AYVAKIT(R) (avapritinib) data showing clinically meaningful outcomes and a w ...

Real-world study of AYVAKIT highlights improvement across ISM symptoms ---- 12 data presentations at 2026 AAAAI Annual ...

Puma Biotechnology issued its 4Q-2025 earnings release on Feb. 26 and followed with a conference call to review results.

Myremill boosts IVF conception rates by 10 with a bespoke Omega-rich flushing mix, enhancing embryo quality and accelerating genetic progress.

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; ...

Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® ...